Neurochemical Mechanisms Induced by High Frequency Stimulation of the Subthalamic Nucleus: Increase of Extracellular Striatal Glutamate and GABA in Normal and Hemiparkinsonian Rats
Open Access
- 1 December 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Neuropathology and Experimental Neurology
- Vol. 62 (12) , 1228-1240
- https://doi.org/10.1093/jnen/62.12.1228
Abstract
High frequency stimulation (HFS) (130 Hz) of the subthalamic nucleus (STN) provides beneficial effects in patients suffering from severe parkinsonism, but the mechanisms underlying these clinical results remain to be clarified. To date, very little is known concerning the effects of STN-HFS on neurochemical transmission in the different basal ganglia nuclei and in particular the striatum. This study examines the effects of STN-HFS in intact and hemiparkinsonian rats on extracellular striatal glutamate (Glu) and GABA levels by means of intracerebral microdialysis. Unilateral STN-HFS was found to induce a significant bilateral increase of striatal Glu and GABA both in intact and in dopamine-lesioned animals. In intact rats, these increases were reversed by local administration of the D1 antagonist SCH 23390, but were potentiated by the D2 antagonist sulpiride. Potentiation was also observed after local administration of both D1 and D2 antagonists whose amplitude was similar to that measured in hemiparkinsonian rats. These data furnish the first evidence that STN-HFS influences striatal amino-acid transmission and that this influence is modulated by dopamine. They provide evidence that the effects of STN-HFS are not only restricted to the direct STN targets, but also involve adaptive changes within other structures of the basal ganglia circuitry.Keywords
This publication has 58 references indexed in Scilit:
- Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidusNeuroscience, 1996
- Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulationThe Lancet, 1995
- Reversal of Rigidity and Improvement in Motor Performance by Subthalamic High‐frequency Stimulation in MPTP‐treated MonkeysEuropean Journal of Neuroscience, 1993
- Subthalamic nucleus cell firing in the 6-OHDA-treated rat: basal activity and response to haloperidolBrain Research, 1992
- Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primateMovement Disorders, 1991
- Lesion of the subthalamic nucleus for the alleviation of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced parkinsonism in the primateMovement Disorders, 1991
- Reversal of Experimental Parkinsonism by Lesions of the Subthalamic NucleusScience, 1990
- Primate models of movement disorders of basal ganglia originTrends in Neurosciences, 1990
- Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonismLife Sciences, 1990
- Altered Tonic Activity of Neurons in the Globus Pallidus and Subthalamic Nucleus in the Primate MPTP Model of ParkinsonismPublished by Springer Nature ,1987